NSE/BSE · Mainboard
Symbiotec Pharmalab Limited
SYMBIOTEC · Exchange-sourced facts, source-labelled market layers, and official milestone links.
UPCOMINGOfficial stale
Price band
₹938–₹988
Book Building
Latest GMP
₹320
2 sources · published · 22 Aug, 09:00 am
Subscription
—
Official bid snapshot unavailable
Listing return
Not available
Post-listing data unavailable
ISSUE TIMELINE
Open24 Aug 2026
Close27 Aug 2026
Basis of allotmentNot announced
RefundNot announced
Demat creditNot announced
ListingNot announced
APPLICATION & ALLOTMENT
Lot size
15 shares
15 shares
Minimum application
₹14,820
₹14,820
Registrar
MUFG Intime India Private Limited
Open official registrarMUFG Intime India Private Limited
Application lot bands
| Category | Lots | Shares | Amount at upper band | Basis |
|---|---|---|---|---|
| Retail | 1–13 | 15–195 | ₹14,820–₹1,92,660 | Derived from official limits |
Lot counts are informational arithmetic from the published bid lot, upper price band, and exchange category limits. They are not an application recommendation.
ISSUE STRUCTURE
Issue size
₹1,757 · 1,87,34,736 shares
₹1,757 · 1,87,34,736 shares
Fresh issue / OFS
₹150 / ₹1,607
₹150 / ₹1,607
Investor reservation (%)
Not published
Not published
Anchor allocation (%)
Not published
Not published
Objects of issue
Not published
Not published
GMP OBSERVATION · UNOFFICIAL
SUBSCRIPTION SNAPSHOTS
Official category-wise subscription snapshots will appear here once the exchange bid feed is published.
COMPANY, FINANCIALS & VALUATION
Lead managers
"JM Financial Limited · Avendus Capital Private Limited · Motilal Oswal Investment Advisors Limited · Nomura Financial Advisory · Securities (India) Private Limited"
"JM Financial Limited · Avendus Capital Private Limited · Motilal Oswal Investment Advisors Limited · Nomura Financial Advisory · Securities (India) Private Limited"
Promoters / post-issue holding
Not published
Not published
| Year | Revenue ₹cr | PAT ₹cr | EPS | NAV | RoNW | D/E |
|---|---|---|---|---|---|---|
| 2026 | 869.15 | 109.9 | — | 109.36 | — | — |
| 2025 | 751.55 | 96.79 | — | — | — | — |
| 2024 | 716.25 | 100.06 | — | — | — | — |
Valuation snapshot: P/E — · P/B — · NAV ₹109.36 · RoNW — · D/E — · Market cap Not available
Peer set: BSE Limited · Pharmalab Limited · Concord Biotech Limited · Laboratories Limited · Lifesciences Limited · Laurus Labs Limited · For Laurus Labs Limited
IPO FAQ
What is GMP?
Grey-market premium is an unofficial, unregulated observation. It can be wrong and is not a listing guarantee.
Does subscription guarantee allotment?
No. Subscription multiples describe exchange-reported demand and do not determine an individual allotment.
Where can allotment be checked?
Use the official registrar link above after the registrar publishes the status. DhanVeda does not submit or scrape the registrar form.
How is listing performance shown?
When an official exchange quote is available, the page compares the issue price with the observed listing and current prices, with timestamps.
OFFICIAL DOCUMENTS & SOURCES
RHP / prospectusE-Form LinkBranches Of Self Certified Syndicate Banks (Scsbs) Where Syndicate / Sub Syndicate Member To Submit Asba FormRatios / Basis Of Issue PriceRed Herring ProspectusBidding CentersSample Application FormsSecurity Parameters (Pre Anchor)Processing Of Asba ApplicationsList Of Mobile Applications Accepting Upi As Payment OptionVideo Link For Upi Based Asba ProcessVideo Link For Bhim Upi RegistrationNSENSE issue informationNSE IPO detailBSE public issue APIBSE IPO detail API
This issue page is an information surface, not an application instruction or listing-gain recommendation. GMP is unofficial and can be wrong; subscription does not guarantee allotment. Use the official exchange, prospectus and registrar links for decisions and allotment checks.